Join us for a virtual event with TScan Therapeutics, featuring hematologist/oncologist Monzr M. Al Malki, MD (City of Hope), discussing the poster presentation and highlights from its ongoing Phase 1 umbrella trial of its lead TCR-T candidates, TSC-100 and TSC-101, in development for the treatment of patients with hematologic malignancies to eliminate residual disease and prevent relapse after allogeneic hematopoietic cell transplantation.

The event will focus on the Phase 1 trial-in-progress poster being presented at the upcoming ASGCT Annual Meeting.

A live question and answer session will follow the formal presentation.